Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Biomedica
2023 Jun 30;432:282-295. doi: 10.7705/biomedica.6611.
Show Gene links
Show Anatomy links
Effects of Mimosa caesalpiniifolia pre-formulation on the intestinal barrier during sodium dextran sulfate-induced colitis in Wistar rats.
Garnevi-Fávero A
,
Nascimento-da Silva K
,
Rodrigues-Ribeiro W
,
Marcantonio-Ferreira C
,
Sartorelli P
,
Cardili L
,
De Cássia-Sinigaglia R
,
Bertaglia-Pereira JN
,
Aparecido-da Silva M
,
Vilegas W
,
Dias-Silva MJ
,
Ribeiro-Paiotti AP
.
???displayArticle.abstract???
INTRODUCTION: Anti-inflammatories, immunosuppressants, and immunobiological are commonly used in the treatment of inflammatory bowel disease. However, some patients do not present an adequate response or lose effective response during the treatment. A recent study found a potential anti-inflammatory effect of the hydroalcoholic extract of Mimosa caesalpiniifolia on trinitrobenzene sulfonic acid-induced colitis in Wistar rats.
OBJECTIVE: To evaluate the effects of M. caesalpiniifolia pre-formulation on the intestinal barrier using dextran sulfate sodium-induced colitis model.
MATERIALS AND METHODS: Leaf extracts were prepared in 70% ethanol and dried with a Buchi B19 Mini-spray dryer using 20% Aerosil® solution. Thirty-two male Wistar rats were randomized into four groups: basal control, untreated colitis, pre-formulation control (125 mg/kg/day), and colitis treated with pre-formulation (125 mg/kg/day). Clinical activity index was recorded daily and all rats were euthanized on the ninth day. Colon fragments were fixed and processed for histological and ultrastructural analyses. Stool samples were collected and processed for analysis of the short-chain fatty acid.
RESULTS: Treatment with the pre-formulation decreased the clinical activity (bloody diarrhea), inflammatory infiltrate, and the ulcers. Pre-formulation did not repair the epithelial barrier and there were no significant differences in the goblet cells index. There was a significant difference in butyrate levels in the rats treated with the pre-formulation.
CONCLUSIONS: The pre-formulation minimized the clinical symptoms of colitis and intestinal inflammation, but did not minimize damage to the intestinal barrier.
Abe,
Arabidopsis AtMYC2 (bHLH) and AtMYB2 (MYB) function as transcriptional activators in abscisic acid signaling.
2003, Pubmed
Abe,
Arabidopsis AtMYC2 (bHLH) and AtMYB2 (MYB) function as transcriptional activators in abscisic acid signaling.
2003,
Pubmed
Abe,
Role of arabidopsis MYC and MYB homologs in drought- and abscisic acid-regulated gene expression.
1997,
Pubmed
Aharoni,
Terpenoid metabolism in wild-type and transgenic Arabidopsis plants.
2003,
Pubmed
Ananthakrishnan,
Environmental risk factors for inflammatory bowel disease.
2013,
Pubmed
Anderson,
Antagonistic interaction between abscisic acid and jasmonate-ethylene signaling pathways modulates defense gene expression and disease resistance in Arabidopsis.
2004,
Pubmed
Arimura,
Herbivore-induced defense response in a model legume. Two-spotted spider mites induce emission of (E)-beta-ocimene and transcript accumulation of (E)-beta-ocimene synthase in Lotus japonicus.
2004,
Pubmed
Arnaud,
Gibberellins control fruit patterning in Arabidopsis thaliana.
2010,
Pubmed
Burger-van Paassen,
The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection.
2009,
Pubmed
Chang,
Intestinal stricture in Crohn's disease.
2015,
Pubmed
Chassaing,
Dextran sulfate sodium (DSS)-induced colitis in mice.
2014,
Pubmed
Cheng,
Electron spin resonance estimation of hydroxyl radical scavenging capacity for lipophilic antioxidants.
2007,
Pubmed
Chichlowski,
Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.
2008,
Pubmed
Cohen,
Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases.
2019,
Pubmed
Dias Silva,
Bioassay-Guided Isolation of Fungistatic Compounds from Mimosa caesalpiniifolia Leaves.
2019,
Pubmed
Dieleman,
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.
1998,
Pubmed
Dostal,
Iron Modulates Butyrate Production by a Child Gut Microbiota In Vitro.
2015,
Pubmed
Garud,
Ulcerative colitis: current treatment strategies and future prospects.
2009,
Pubmed
Khor,
Genetics and pathogenesis of inflammatory bowel disease.
2011,
Pubmed
McGuckin,
Intestinal secretory cell ER stress and inflammation.
2011,
Pubmed
Nighot,
Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
2015,
Pubmed
Okayasu,
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.
1990,
Pubmed
Rakotomalala,
Extract from Mimosa pigra attenuates chronic experimental pulmonary hypertension.
2013,
Pubmed
Rejón-Orantes,
Aqueous root extracts from Mimosa albida Humb. & Bonpl. ex Willd display antinociceptive activity in mice.
2013,
Pubmed
Ribeiro,
Use of Gas Chromatography to Quantify Short Chain Fatty Acids in the Serum, Colonic Luminal Content and Feces of mice.
2018,
Pubmed
Rivera-Arce,
Therapeutic effectiveness of a Mimosa tenuiflora cortex extract in venous leg ulceration treatment.
2007,
Pubmed
Sales-Campos,
Classical and recent advances in the treatment of inflammatory bowel diseases.
2015,
Pubmed
Silva,
The Anti-Inflammatory Potential of Mimosa caesalpiniifolia Following Experimental Colitis: Role of COX-2 and TNF-Alpha Expression.
2018,
Pubmed
Sánchez-Fidalgo,
Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice.
2013,
Pubmed
Tedelind,
Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.
2007,
Pubmed
Van Itallie,
Architecture of tight junctions and principles of molecular composition.
2014,
Pubmed
de Albuquerque,
Is the use-impact on native caatinga species in Brazil reduced by the high species richness of medicinal plants?
2007,
Pubmed
